Conopeptides as Modulators of Pain and Inflammation in Chemotherapy-Induced Peripheral Neuropathy by Targeting α7 and α9 Nicotinic Acetylcholine Receptors

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Neurotoxicity research

• Publication date

  2026-01-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s12640-025-00778-8PMID 41499076
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conotoxins: Classification, Prediction, and Future Directions in Bioinformatics

  2025cited by this paper
• Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines

  2025cited by this paper
• Cholinergic signaling via the α7 nicotinic acetylcholine receptor regulates the migration of monocyte-derived macrophages during acute inflammation

  2024cited by this paper
• Development of an Intravenously Stable Disulfide-Rich Peptide for the Treatment of Chemotherapy-Induced Neuropathic Pain.

  2024cited by this paper
• Secondary Metabolites from the Mangrove Ecosystem-Derived Fungi Penicillium spp.: Chemical Diversity and Biological Activity

  2024cited by this paper
• N-Terminal Capping of the αO-Conotoxin Analogue GeX-2 Improves the Serum Stability and Selectivity toward the Human α9α10 Nicotinic Acetylcholine Receptor.

  2024cited by this paper
• ConoDL: A Deep Learning Framework for Rapid Generation and Prediction of Conotoxins

  2024cited by this paper
• Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment

  2024cited by this paper
• A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy treatment (ACT).

  2024cited by this paper
• Functions and pharmacology of α2β2 nicotinic acetylcholine receptors; in and out of the shadow of α4β2 nicotinic acetylcholine receptors.

  2024cited by this paper
• αO-Conotoxin GeXIVA[1,2] Reduced Neuropathic Pain and Changed Gene Expression in Chronic Oxaliplatin-Induced Neuropathy Mice Model

  2024cited by this paper
• Bibliometric Review of the Literature on Cone Snail Peptide Toxins from 2000 to 2022

  2023cited by this paper
• Small molecule ligands for α9* and α7 nicotinic receptors: a survey and an update, respectively.

  2023cited by this paper
• α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain

  2023cited by this paper
• Signaling of nicotinic acetylcholine receptors in mononuclear phagocytes.

  2023cited by this paper
• N-type calcium channel blockers: a new approach towards the treatment of chronic neuropathic pain

  2023cited by this paper
• Selective α3β4 Nicotinic Acetylcholine Receptor Ligand as a Potential Tracer for Drug Addiction

  2023cited by this paper
• Conotoxin Patenting Trends in Academia and Industry

  2022cited by this paper
• RgIA4 Prevention of Acute Oxaliplatin-Induced Cold Allodynia Requires α9-Containing Nicotinic Acetylcholine Receptors and CD3+ T-Cells

  2022cited by this paper
• Mechanisms of Chemotherapy-Induced Neurotoxicity

  2022cited by this paper
• Selective Agonists and Antagonists of α9 Versus α7 Nicotinic Acetylcholine Receptors.

  2022cited by this paper
• Structural and functional insights into the inhibition of human voltage-gated sodium channels by μ-conotoxin KIIIA disulfide isomers

  2022cited by this paper
• Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms

  2022cited by this paper
• Mechanisms and Pathways of Pain Photobiomodulation: A Narrative Review.

  2021cited by this paper
• α-Conotoxin RgIA and oligoarginine R8 in the mice model alleviate long-term oxaliplatin induced neuropathy.

  2021cited by this paper
• ɑO‐Conotoxin GeXIVA isomers modulate N‐type calcium (CaV2.2) channels and inwardly‐rectifying potassium (GIRK) channels via GABAB receptor activation

  2021cited by this paper
• Identification of Novel Conotoxin Precursors from the Cone Snail Conus spurius by High-Throughput RNA Sequencing

  2021cited by this paper
• Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues

  2021cited by this paper
• Pain Relieving and Neuroprotective Effects of Non-opioid Compound, DDD-028, in the Rat Model of Paclitaxel-Induced Neuropathy

  2021cited by this paper
• Structure and gating mechanism of the α7 nicotinic acetylcholine receptor.

  2021cited by this paper
• Post-translationally modified conopeptides: Biological activities and pharmacological applications.

  2021cited by this paper
• Diversity of Conopeptides and Their Precursor Genes of Conus Litteratus

  2020cited by this paper
• Equilibrative Nucleoside Transporters-1 Inhibitors Act as Anti-epileptic Agents by Inhibiting Glutamatergic Transmission

  2020cited by this paper
• Interactions of the α3β2 Nicotinic Acetylcholine Receptor Interfaces with α-Conotoxin LsIA and its Carboxylated C-terminus Analogue: Molecular Dynamics Simulations

  2020cited by this paper
• Structure-Function of Neuronal Nicotinic Acetylcholine Receptor Inhibitors Derived From Natural Toxins

  2020cited by this paper
• Hormone-like conopeptides - new tools for pharmaceutical design.

  2020cited by this paper
• A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models

  2020cited by this paper
• The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain

  2019cited by this paper
• Nicotine Evoked Currents in Human Primary Sensory Neurons.

  2019cited by this paper
• Rationally Designed α-Conotoxin Analogues Maintained Analgesia Activity and Weakened Side Effects

  2019cited by this paper
• ‘Messy’ Processing of χ-conotoxin MrIA Generates Homologues with Reduced hNET Potency

  2019cited by this paper
• Chemotherapy-induced peripheral neuropathy: where are we now?

  2019cited by this paper
• The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal.

  2019cited by this paper
• The effect of analgesics on stimulus evoked pain-like behaviour in animal models for chemotherapy induced peripheral neuropathy- a meta-analysis

  2019cited by this paper
• RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats

  2019cited by this paper
• Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors

  2018cited by this paper
• Comparative Physiology of Nociception and Pain.

  2018cited by this paper
• Nicotinic acetylcholine receptors in neuropathic and inflammatory pain

  2018cited by this paper
• α9‐containing nicotinic acetylcholine receptors and the modulation of pain

  2018cited by this paper
• Peripheral neuropathy in children and adolescents treated for cancer.

  2018cited by this paper
• Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy

  2017cited by this paper
• RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia

  2017cited by this paper
• Disulfide Bonds: A Key Modification in Bacterial Extracytoplasmic Proteins

  2017cited by this paper
• Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy

  2017cited by this paper
• Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain

  2017cited by this paper
• The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.

  2016cited by this paper
• α4β2 Nicotinic Acetylcholine Receptors

  2016cited by this paper
• [Physiology of pain].

  2015cited by this paper
• Physiologie des Schmerzes

  2015cited by this paper
• Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)

  2015cited by this paper
• Inflammation-induced increase in nicotinic acetylcholine receptor current in cutaneous nociceptive DRG neurons from the adult rat.

  2015cited by this paper
• Functional expression and axonal transport of α7 nAChRs by peptidergic nociceptors of rat dorsal root ganglion

  2015cited by this paper
• Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation.

  2014cited by this paper
• Conotoxin Gene Superfamilies

  2014cited by this paper
• Conotoxins Targeting Nicotinic Acetylcholine Receptors: An Overview

  2014cited by this paper
• Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms.

  2014cited by this paper
• Comparative functional expression of nAChR subtypes in rodent DRG neurons

  2013cited by this paper
• Nicotinic acetylcholine receptor and the structural basis of neuromuscular transmission: insights from Torpedo postsynaptic membranes

  2013cited by this paper
• Deep Venomics Reveals the Mechanism for Expanded Peptide Diversity in Cone Snail Venom*

  2012cited by this paper
• Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α‐conotoxin RgIA

  2012cited by this paper
• From DNA Enzymes to Cone Snail Venom: The Work of Baldomero M. Olivera

  2012cited by this paper
• α6 nAChR subunit residues that confer α‐conotoxin BuIA selectivity

  2012cited by this paper
• Two Neuronal Nicotinic Acetylcholine Receptors, α4β4 and α7, Show Differential Agonist Binding Modes*

  2011cited by this paper
• Expression of Functional Human α6β2β3* Acetylcholine Receptors in Xenopus laevis Oocytes Achieved through Subunit Chimeras and Concatamers

  2011cited by this paper
• Conopeptide characterization and classifications: an analysis using ConoServer.

  2010cited by this paper
• Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads.

  2009cited by this paper
• A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain

  2009cited by this paper
• Non-neuronal nicotinic acetylcholine receptors: Cholinergic regulation of the immune processes

  2007cited by this paper
• Nicotinic AChR in subclassified capsaicin-sensitive and -insensitive nociceptors of the rat DRG.

  2005cited by this paper
• Publisher's Note

  2003cited by this paper
• Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons.

  2002cited by this paper
• Coexpression of α9 and α10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons

  2002cited by this paper
• [Physiology of pain].

  1960cited by this paper

• No citing papers are available for this paper.